2 Sources
[1]
AI model identifies high-risk heart failure phenotype in diabetes
Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart's structure and function that predisposes them to an increased risk of heart failure. The
[2]
AI tool helps identify heart failure risk in diabe | Newswise
DALLAS - Oct. 22, 2024 - Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart's structure and function that predisposes them to increased risk
Share
Copy Link
Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, potentially enabling early interventions to prevent heart failure in high-risk individuals with diabetes.

Researchers at UT Southwestern Medical Center have developed a groundbreaking machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart's structure and function. This condition predisposes patients to an increased risk of heart failure. The findings, published in the European Journal of Heart Failure, offer a data-driven method to detect a high-risk diabetic cardiomyopathy phenotype, potentially enabling early interventions to prevent heart failure in this vulnerable population
1
2
.The research team, led by Dr. Ambarish Pandey, Associate Professor of Internal Medicine in the Division of Cardiology at UT Southwestern, utilized data from the Atherosclerosis Risk in Communities cohort. This dataset included over 1,000 participants with diabetes but no history of cardiovascular disease. By analyzing 25 echocardiographic parameters and cardiac biomarkers, the team identified three distinct patient subgroups
1
2
.One subgroup, comprising 27% of the cohort, was identified as the high-risk phenotype. Patients in this group exhibited:
Most notably, the five-year incidence of heart failure in this high-risk group was 12.1%, significantly higher than in the other subgroups
1
2
.Based on these findings, the researchers developed a deep neural network classifier to identify diabetic cardiomyopathy. The model was validated on additional cohorts, including the Cardiovascular Health Study and UT Southwestern's electronic health record database. Results showed that the model identified between 16% and 29% of diabetic patients as having the high-risk phenotype, with these patients consistently exhibiting a higher incidence of heart failure
1
2
.Related Stories
Dr. Pandey emphasized the potential clinical applications of this model: "This model could help target intensive preventive therapies, such as SGLT2 inhibitors, to patients most likely to benefit. It may also help enrich clinical trials of heart failure prevention strategies in diabetes patients"
1
2
.The study expands on earlier research into diabetic cardiomyopathy, which has been challenging to define due to its asymptomatic early stages and varied effects on the heart. This machine learning approach offers a more refined method for identifying high-risk patients compared to traditional diagnostic techniques
1
2
.By providing a new way to identify patients at risk for heart failure, the model could enable earlier and more aggressive interventions, potentially improving patient outcomes and shaping future research in cardiovascular care. The research aligns with UT Southwestern's mission by leveraging strengths in data science and cardiovascular research to develop tools that could enhance patient care and inform future clinical trials
1
2
.This innovative approach to identifying high-risk diabetic cardiomyopathy demonstrates the growing potential of AI and machine learning in healthcare, particularly in early disease detection and personalized treatment strategies.
Summarized by
Navi
[1]
1
Technology

2
Policy and Regulation

3
Technology
